N6 Input Processing in Traditional CI Recipients
Launched by COCHLEAR · Sep 11, 2014
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Greater than 12 years
- • Unilateral cochlear implant recipient (CI24RE, CI500, CI422)
- • Minimum of 3 months experience with the N5 sound processor
- • Prior documentation of sentence recognition testing in noise at a difficulty of +10 dB SNR or better
- • Native English speaker
- • Willingness to participate in and comply with all requirements of the protocol
- Exclusion Criteria:
- • Unrealistic expectations
- • Unwillingness to comply with investigational requirements of the protocol
- • Additional handicaps that would prevent or restrict participation in the evaluations
About Cochlear
Cochlear Limited is a global leader in implantable hearing solutions, dedicated to transforming the lives of individuals with hearing loss through innovative technology and comprehensive clinical research. With a strong commitment to advancing auditory rehabilitation, Cochlear conducts rigorous clinical trials aimed at evaluating the safety and efficacy of its products, including cochlear implants and bone conduction devices. The company collaborates with healthcare professionals and research institutions worldwide to ensure that its solutions meet the highest standards of quality and performance, ultimately enhancing patient outcomes and promoting accessibility to hearing health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Englewood, Colorado, United States
Chesterfield, Missouri, United States
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials